Uncertainty-Aware Ordinal Deep Learning for cross-Dataset Diabetic Retinopathy Grading
This work addresses the problem of reliable and robust diabetic retinopathy grading for clinical applications, with incremental improvements in uncertainty estimation and cross-dataset generalization.
The paper tackled automated diabetic retinopathy severity grading by proposing an uncertainty-aware deep learning framework that models disease progression ordinally, achieving competitive classification accuracy and high quadratic weighted kappa on cross-dataset tests.
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insufficient insulin production or impaired insulin utilization. One of its most severe complications is diabetic retinopathy (DR), a progressive retinal disease caused by microvascular damage, leading to hemorrhages, exudates, and potential vision loss. Early and reliable detection of DR is therefore critical for preventing irreversible blindness. In this work, we propose an uncertainty-aware deep learning framework for automated DR severity grading that explicitly models the ordinal nature of disease progression. Our approach combines a convolutional backbone with lesion-query attention pooling and an evidential Dirichlet-based ordinal regression head, enabling both accurate severity prediction and principled estimation of predictive uncertainty. The model is trained using an ordinal evidential loss with annealed regularization to encourage calibrated confidence under domain shift. We evaluate the proposed method on a multi-domain training setup combining APTOS, Messidor-2, and a subset of EyePACS fundus datasets. Experimental results demonstrate strong cross-dataset generalization, achieving competitive classification accuracy and high quadratic weighted kappa on held-out test sets, while providing meaningful uncertainty estimates for low-confidence cases. These results suggest that ordinal evidential learning is a promising direction for robust and clinically reliable diabetic retinopathy grading.